Daily News Podcast

Opioids do more harm than good for musculoskeletal pain

Publish date: June 27, 2018

 

Opioids cannot be justified for the routine treatment for musculoskeletal pain because risks outweigh benefits. Also today, intensive treatment for type 2 diabetes pays off in the long run, diabetes patients are being pushed into high-deductible insurance plans, and obesity didn’t just happen overnight.

Listen to the MDedge Daily News podcast for all the details on today’s top news.

Recommended Reading

TNF inhibitor linked to one-third drop in total mortality
MDedge Rheumatology
Routine AAA screening for older men: more harm than good?
MDedge Rheumatology
TNF inhibitor linked to one-third drop in total mortality
MDedge Rheumatology
Inflammatory myopathy following tattoo reported in an immunocompromised patient
MDedge Rheumatology
Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Rheumatology
Canakinumab cut gout attacks in CANTOS
MDedge Rheumatology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Rheumatology
JAK inhibitor therapy promising for refractory dermatomyositis
MDedge Rheumatology
Patients going without as insulin prices skyrocket
MDedge Rheumatology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Rheumatology